OREMAVEN
XMM 7,722.00 -2.63% YTD +5.6% OM ASX 450.55 -2.56% YTD +0.1% OM PRECIOUS 349.20 -2.24% YTD +2.5% OM EX-PREC 418.91 -2.72% YTD -1.1% XAU 4,115.59 +2.31% YTD -4.9% GLD 375.49 +0.81% YTD -5.2% GDX 85.75 +1.37% YTD -0.0% SIL 77.33 -1.00% YTD -7.3% COPX 70.23 -5.81% YTD -1.8% URNM 40.07 -2.79% YTD -27.0%
2026-11-06

← IG6 management

Full background report

Christoph Frey

Technical adviser (disclosed March 2026; continuation unconfirmed)

Career chronology

  • Issuer presentation identifies role in March 2026; continuation at cutoff unconfirmed: International Graphite — Technical adviser. PDAC presentation (p.15)

  • At source access; start date not established: ProGraphite GmbH — Founder and managing director. About Us (Christoph Frey biography); Renascor and Dorfner v EcoGraf [2024] APO 13 (pp.4–5 applicant witnesses)

Personal achievements

Inventor of graphite purification patent

2024–2025 · documented · medium materiality

The 2024 Australian Patent Office decision identifies Frey as inventor of EcoGraf application 2021261902 and records successful oppositions to then-filed claims on several grounds, with the applicant allowed to amend. EcoGraf reported that IP Australia granted the patent in August 2025 following finalisation of the oppositions.

Attribution: Individual involvement documented. Frey was a named inventor and provided evidence; the opposition is an intellectual-property dispute, not a personal misconduct finding. The later grant is company-reported.

Relevance: Technical development experience is relevant to the advisory role; later grant is material to the result.

Renascor and Dorfner v EcoGraf [2024] APO 13 (decision pp.1–5); EcoGraf HFfree first Australian patent granted (p.1)

Suitability for the current role

Graphite process expertise

March 2026, continuation unconfirmed · analyst inference · medium materiality

The March 2026 IG6 presentation identifies Frey as a technical advisor and describes his ProGraphite and former AMG graphite roles. The detailed employment periods and continued advisory engagement at the cutoff are not independently established.

Attribution: Responsibility not applicable. Role-fit assessment is an inference from the issuer biography; it does not establish delivery outcomes.

Relevance: Relevant graphite expertise with a material current-engagement gap.

PDAC presentation (p.15)

Evidence gaps

  • The issuer’s March 2026 adviser listing does not establish continued engagement on 31 October 2026.

  • Independent verification of professional qualifications, full past tenures and German regulatory/court records is incomplete.

  • Actual commercial role, payments and contractual terms with IG6 are not established from the cited sources.

  • Historical 9 October search-log entries are inherited and their execution and exact scope could not be independently reconstructed in the 31 October audit. Broad keyword searches do not establish complete person-specific regulatory, court, safety or environmental coverage.